FDA.reportPublic FDA data

Uqora Maximum UTI Pain Relief and Flush Convenience Bundle

Manufacturer
Bonafide Health, LLC dba Uqora | Pharbest
Effective date
2025-11-10
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:43:18

Label at a glance#

ProductUqora Maximum UTI Pain Relief and Flush Convenience Bundle
Active ingredientPHENAZOPYRIDINE HYDROCHLORIDE
Label structure3 sections

Label contents#

Full prescribing information#

Uqora Maximum UTI Pain Relief

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Phenazopyridine Hydrochloride 99.5 mg

Purpose

OTC - PURPOSE SECTION

Active ingredient (in each tablet)

Purpose
Phenazopyridine Hydrochloride 99.5mgUrinary Tract Analgesic

Use

INDICATIONS & USAGE SECTION

Fast relief from urinary pain, burning, urgency and frequency associated with urinary tract infections. Treatment should not exceed 2 days; see Directions.

Warnings

WARNINGS SECTION

Do not exceed recommended dosage

Do Not Use

OTC - DO NOT USE SECTION

Do not use:

  • If you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician
Ask A Doctor Before Use

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have:

  • kidney disease
  • allergies to foods, preservatives or dyes
  • had a hypersensitive reaction to phenazopyridine
When Using This Product

OTC - WHEN USING SECTION

When using this product:

  • stomach upset may occur, taking this product with or after meals may reduce stomach upset
  • your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.
Stop Use And Ask A Doctor

OTC - STOP USE SECTION

Stop use and ask a doctor if:

  • your symptoms last for more than 2 days
  • you suspect you are having an adverse reaction to the medication
Long Term Administration

SPL UNCLASSIFIED SECTION

Long-term administration of phenazopyridine hydrochloride has induced neoplasia in rats (large intestine) and mice (liver). Although
no association between phenazopyridine hydrochloride and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted.

If Pregnant or Breast Feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast feeding, ask a health professional before use.

Keep Out Of The Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of the reach of children.In case of overdose, get medical help or contact a Poison Control Center right away 1-800-222-1222

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years and over:

take 2 tablets 3 times daily with a full glass of water, with or after meals as needed
Do not use for more than 2 days (12 tablets) without consulting a doctor.

Children under 12 years:consult a doctor

Other Information

STORAGE AND HANDLING SECTION

  • this product may stain contact lenses
  • this product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests
  • store at room temperature 15°-30°C (59°-86°F) in a dry place and protect from light
  • Tamper evident: tablets sealed in blisters. Do not use if blister foil or seal is open or damaged

Inactive ingredients

INACTIVE INGREDIENT SECTION

corn starch, croscarmellose sodium, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinylpyrrolidone, pregelatinized starch, silicon dioxide, sodium starch glycolate, talc and triacetin.

Additional Items

SPL UNCLASSIFIED SECTION

FLUSH Urinary Tract Drink Mix

2 packets

Dietary Supplement

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

uqora

Founded by a UTI Sufferer

Get Relief

Get Ahead

Convenience Bundle Pack

UTI Pain Relief Max Strength*

Fast targeted relief for pain, burning & urgency

2 Day Supply

12 tablets

99.5 mg Phenazopyridine Hydrochloride

Packaged for convenience.

Not intended to replace medical care.

*Most powerful dose without an Rx.

&

Flush Urinary Tract Drink Mix

Clinical Strength

D-Mannose per serving

Flushes your urinary tract + immune support*

Pink Lemonade Flavor

2 packets

Dietary Supplement

Net Wt. 0.3OZ(10G

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

11

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1094147phenazopyridine HCl 99.5 MG Oral TabletPSN1
1094147phenazopyridine hydrochloride 99.5 MG Oral TabletSCD1
1094147phenazopyridine HCl 99.5 MG Oral TabletSY1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73712-114-12Uqora Maximum UTI Pain Relief and Flush Convenience Bundle12 in 1 BLISTER PACKTABLET1299.5 mg1
73712-114-12Uqora Maximum UTI Pain Relief and Flush Convenience Bundle1 in 1 CARTONTABLET99.5 mg1
73712-600-12Uqora Maximum UTI Pain Relief and Flush Convenience Bundle1 in 1 KITKIT11

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73712-60073712-600-12
73712-11473712-114-12

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Name, UNII, Kind table
NameUNIIKind
POLYETHYLENE GLYCOL, UNSPECIFIED3WJQ0SDW1AIACT
HYPROMELLOSES3NXW29V3WOIACT
MAGNESIUM STEARATE70097M6I30IACT
SILICON DIOXIDEETJ7Z6XBU4IACT
SODIUM STARCH GLYCOLATE TYPE AH8AV0SQX4DIACT
CROSCARMELLOSE SODIUMM28OL1HH48IACT
LACTOSE, UNSPECIFIED FORMJ2B2A4N98GIACT
POVIDONE, UNSPECIFIEDFZ989GH94EIACT
TALC7SEV7J4R1UIACT
TRIACETINXHX3C3X673IACT
STARCH, CORNO8232NY3SJIACT
CELLULOSE, MICROCRYSTALLINEOP1R32D61UIACT
PHENAZOPYRIDINE HYDROCHLORIDE0EWG668W17ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
All-In-One UTI Emergency KitMETHENAMINE, SODIUM SALICYLATE, AND PHENAZOPYRIDINE HYDROCHLORIDEBonafide Health, LLC dba Uqora434652a1-583e-d6f7-e063-6394a90aab8a2025-11-10WarningsExact identifier
ndc (package): 73712-114-12
ndc11 (package): 73712011412
Uqora Maximum UTI Pain Relief and Flush Convenience BundlePHENAZOPYRIDINE HYDROCHLORIDEBonafide Health, LLC dba Uqora4354dcce-6d85-4584-e063-6294a90a56162025-11-10WarningsExact identifier
ndc (package): 73712-600-12
ndc (package): 73712-114-12
ndc (product): 73712-600
ndc11 (package): 73712011412
ndc11 (package): 73712060012
spl id: 4354e016-91fe-d3c9-e063-6394a90af8d9
spl set id: 4354dcce-6d85-4584-e063-6294a90a5616
Uqora Maximum UTI Pain ReliefPHENAZOPYRIDINE HYDROCHLORIDEBonafide Health, LLC dba Uqora426317e7-a925-116a-e063-6294a90a52dc2025-10-27WarningsExact identifier
ndc (package): 73712-114-12
ndc (product): 73712-114
ndc11 (package): 73712011412

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.